Data Support First Approved Treatment for Acute Hepatitis C

(MedPage Today) -- The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute hepatitis C virus (HCV) infection, according to results from a multicenter phase IIIb trial.
Among 286...